11/20091 EPI 5240: Introduction to Epidemiology Confounding: concepts and general approaches November 9, 2009 Dr. N. Birkett, Department of Epidemiology.

Slides:



Advertisements
Similar presentations
M2 Medical Epidemiology
Advertisements

Holland on Rubin’s Model Part II. Formalizing These Intuitions. In the 1920 ’ s and 30 ’ s Jerzy Neyman, a Polish statistician, developed a mathematical.
Observational Designs Oncology Journal Club April 26, 2002.
1 Confounding and Interaction: Part II  Methods to Reduce Confounding –during study design: »Randomization »Restriction »Matching –during study analysis:
Confounding and Interaction: Part II  Methods to reduce confounding –during study design: »Randomization »Restriction »Matching –during study analysis:
Confounding and Interaction: Part II
Chapter 19 Stratified 2-by-2 Tables
CAUSAL REASONING; CONFOUNDING (INTRODUCTION) Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa 5/6/2014 SUMMER COURSE:
Chance, bias and confounding
2.6 The Question of Causation. The goal in many studies is to establish a causal link between a change in the explanatory variable and a change in the.
Confounding and Interaction: Part II
1June In Chapter 19: 19.1 Preventing Confounding 19.2 Simpson’s Paradox (Severe Confounding) 19.3 Mantel-Haenszel Methods 19.4 Interaction.
Categorical Data Analysis: Stratified Analyses, Matching, and Agreement Statistics Biostatistics March 2007 Carla Talarico.
Epidemiology Kept Simple
COHORT AND CASE-CONTROL DESIGNS Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa SUMMER COURSE: INTRODUCTION TO EPIDEMIOLOGY.
THREE CONCEPTS ABOUT THE RELATIONSHIPS OF VARIABLES IN RESEARCH
Dr K N Prasad MD., DNB Community Medicine
Designing Clinical Research 2009 Confounding and Causal Inference Warren Browner.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 12: Multiple and Logistic Regression Marshall University.
Case Control Study Manish Chaudhary BPH, MPH
Stratification and Adjustment
INTRODUCTION TO EPIDEMIOLO FOR POME 105. Lesson 3: R H THEKISO:SENIOR PAT TIME LECTURER INE OF PRESENTATION 1.Epidemiologic measures of association 2.Study.
Unit 6: Standardization and Methods to Control Confounding.
Gerstman Case-Control Studies 1 Epidemiology Kept Simple Section 11.5 Case-Control Studies.
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Confounding and Interaction: Part II  Methods to reduce confounding –during study design: »Randomization »Restriction »Matching –during study analysis:
Consumer Preference Test Level 1- “h” potato chip vs Level 2 - “g” potato chip 1. How would you rate chip “h” from 1 - 7? Don’t Delicious like.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Retrospective Cohort Study. Review- Retrospective Cohort Study Retrospective cohort study: Investigator has access to exposure data on a group of people.
ECON ECON Health Economic Policy Lab Kem P. Krueger, Pharm.D., Ph.D. Anne Alexander, M.S., Ph.D. University of Wyoming.
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Confounding, Matching, and Related Analysis Issues Kevin Schwartzman MD Lecture 8a June 22, 2005.
Amsterdam Rehabilitation Research Center | Reade Multiple regression analysis Analysis of confounding and effectmodification Martin van de Esch, PhD.
COMH7202: EPIDEMIOLOGY III – INTERMEDIATE CONCEPTS Confounding & Effect Modification
Introduction to confounding and DAGs
October 15. In Chapter 19: 19.1 Preventing Confounding 19.2 Simpson’s Paradox 19.3 Mantel-Haenszel Methods 19.4 Interaction.
01/20151 EPI 5344: Survival Analysis in Epidemiology Survival curve comparison (non-regression methods) March 3, 2015 Dr. N. Birkett, School of Epidemiology,
Experiments and Causal Inference ● We had brief discussion of the role of randomized experiments in estimating causal effects earlier on. Today we take.
Analytical epidemiology Disease frequency Study design: cohorts & case control Choice of a reference group Biases Alain Moren, 2006 Impact Causality Effect.
Case Control Study Dr. Ashry Gad Mohamed MB, ChB, MPH, Dr.P.H. Prof. Of Epidemiology.
1 EPI 5240: Introduction to Epidemiology Measures used to compare groups October 5, 2009 Dr. N. Birkett, Department of Epidemiology & Community Medicine,
Basic concept of clinical study
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Instructor Resource Chapter 14 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
Case Control Study : Analysis. Odds and Probability.
Psy 311: Methods1 GOALS OF DEVELOPMENTAL PSYCHOLOGY l Describe, explain, and optimize human development.
Principles of case control studies
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
01/20151 EPI 5344: Survival Analysis in Epidemiology Cox regression: Introduction March 17, 2015 Dr. N. Birkett, School of Epidemiology, Public Health.
31/7/20091 Summer Course: Introduction to Epidemiology August 21, Confounding: control, standardization Dr. N. Birkett, Department of Epidemiology.
Instructor Resource Chapter 15 Copyright © Scott B. Patten, Permission granted for classroom use with Epidemiology for Canadian Students: Principles,
01/20151 EPI 5344: Survival Analysis in Epidemiology Confounding and Effect Modification March 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
Design of Clinical Research Studies ASAP Session by: Robert McCarter, ScD Dir. Biostatistics and Informatics, CNMC
POPLHLTH 304 Regression (modelling) in Epidemiology Simon Thornley (Slides adapted from Assoc. Prof. Roger Marshall)
Matched Case-Control Study Duanping Liao, MD, Ph.D Phone:
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Introduction to Biostatistics, Harvard Extension School, Fall, 2005 © Scott Evans, Ph.D.1 Contingency Tables.
Case control & cohort studies
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 13: Multiple, Logistic and Proportional Hazards Regression.
(www).
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
Epidemiology 503 Confounding.
Lecture 3: Introduction to confounding (part 1)
Evaluating Effect Measure Modification
The Aga Khan University
Confounders.
Case-control studies: statistics
Effect Modifiers.
Presentation transcript:

11/20091 EPI 5240: Introduction to Epidemiology Confounding: concepts and general approaches November 9, 2009 Dr. N. Birkett, Department of Epidemiology & Community Medicine, University of Ottawa

11/20092 Earlier session introduced confounding THERE MUST BE THREE VARIABLES!!! ‘Usual approach’ is based on ‘causation triad’ –Related to exposure –Related to outcome –Not part of the causal pathway These criteria aren’t ‘quite’ right No-one actually uses this approach in real research We will introduce new ideas and expand on the triad.

11/20093 Confounding (1) Dementia Yes No Total Yes ,000 No , ,000 1,000 Diabetes Risk in exposed: = 400/1000 = 0.4 Risk in Non-exposed= 100/1000 = 0.1 Risk ratio (RR) = 0.4/0.1 = 4.0 CRUDE table

11/20094 Confounding (2) Dementia Yes No Total Yes No ,000 Risk in exposed: = 21/100 = 0.21 Risk in Non-exposed= 79/900 = Risk ratio (RR) = 0.21/0.088 = Risk in exposed: = 379/900 = 0.42 Risk in Non-exposed= 21/100 = 0.21 Risk ratio (RR) = 0.42/0.21 = 2.01 Dementia Yes No Total Yes No , Best ‘guess’ of RR would be about 2.2, not 4.0!!

11/20095 Confounding (3) Previous example is confounding –The estimate of the effect of an exposure is distorted or confounded by a third factor. –We’ll come to ‘why’ in a minute. –Tables in previous slide are called stratified tables (here, age stratified). Let’s consider a new situation based on the same crude table.

11/20096 Confounding (4) Dementia Yes No Total Yes No ,000 Risk in exposed: = 5/100 = 0.05 Risk in Non-exposed= 95/900 = Risk ratio (RR) = 0.05/0.106 = Risk in exposed: = 395/900 = 0.44 Risk in Non-exposed= 5/100 = 0.05 Risk ratio (RR) = 0.44/0.05 = 8.78 Dementia Yes No Total Yes No , What is best ‘guess’ of RR? It depends on age. There is no single answer!

11/20097 Confounding (5) Previous example is effect modification –The effect of an exposure on an outcome depends on the level of a third variable –In this example: For people under age 79, it looks like diabetes protects against dementia For people over age 80, it looks like diabetes increases the risk of getting dementia, No single number or statement is an appropriate summary when this pattern occurs. –Links statistically to interactions. Gene-environment interactions are a ‘hot’ topic of study.

11/20098 Confounding (5A) We’re not going to talk more about effect modification today.

11/20099 Confounding (6) Why was there confounding? –Numerical/mathematical answer can be given but let’s talk more conceptually. Does heavy alcohol drinking cause mouth cancer? –A case-control study was done which found an OR of 3.2 (95% CI: 2.1 to 4.9). –Does this prove the case? –Consider the following situations.

11/ Confounding (7) Alcohol mouth cancer This is what we are trying to prove. But, we know that smoking can cause mouth cancer. And, people who drink heavily tend, in general, to be heavy smokers. So, we might have:

11/ Confounding (8) Alcohol mouth cancer ??? Smoking The association between alcohol and mouth cancer is explained away by the link to smoking. Adjusted OR is 1.1 (95% CI: 0.6 to 2.0).

11/ Confounding (9) Confounding requires three or more variables. –Two variables, each with multiple levels, cannot produce confounding. Three requirements for confounding –Confounder relates to outcome –Confounder relates to exposure –Confounder is not part of causal pathway between exposure and outcome

11/ Confounding (9A) Requirements aren’t this simple For case-control study, you need: –Confounder is related to exposure in the control group (OR≠1.) –Confounder is related to the outcome in the unexposed group (OR≠1.)

11/ Confounding (10) In our initial dementia example, we have: –OR relating age and dementia in people without diabetes = 2.8 –OR relating age and diabetes in people without dementia = 68.5 –There is no suggestion that diabetes causes dementia because people are getting older.

11/ Confounding (11) In ‘real’ research, these three ‘rules’ are not applied to identify confounding. –Inefficient and prone to false negatives Instead, we compute an adjusted RR or OR and compare this to the crude RR or OR [Change of Estimate method]. –If these differ enough to ‘matter’, then we say there is confounding. Usual guideline is a 10% change.

11/ Confounding (12) Dementia Yes No Total Yes ,000 No , ,000 1,000 Diabetes Risk in exposed: = 400/1000 = 0.4 Risk in Non-exposed= 100/1000 = 0.1 Risk ratio (RR) = 0.4/0.1 = 4.0 CRUDE table

11/ Confounding (13) Dementia Yes No Total Yes No ,000 Risk in exposed: = 21/100 = 0.21 Risk in Non-exposed= 79/900 = Risk ratio (RR) = 0.21/0.088 = Risk in exposed: = 379/900 = 0.42 Risk in Non-exposed= 21/100 = 0.21 Risk ratio (RR) = 0.42/0.21 = 2.01 Dementia Yes No Total Yes No , How to ‘adjust’ the OR?

11/ Confounding (14) How to adjust? –Topic for later class Basic idea is that a good ‘guess’ is in the middle between the two strata-specific OR’s Take an average BUT weight the average in some way –USE board to explain weighted average.

11/ Confounding (15) Confounding can be complex and controversial –Presence of confounding can depend on analysis scale Multiplicative vs. additive Works best for simple situations (e.g. only three variables) The basic idea is to look for the independent effect of each variable BUT, suppose the etiology is more complex?

11/ Web of Causation sample

11/ /7/ Confounding (16) How do we deal with confounding? –Prevention You need to ‘break’ one of the links between the confounder and the exposure or outcome –‘Treatment’ (analysis) Stratified analysis (like my simple example) Standardization (we’ll discuss this later) Regression modeling methods (covered in a different course )

11/ /7/ Confounding (17) Prevention –Randomization One of the big advantages of an RCT –Restriction Limits the subject to one level of confounder (e.g. study effect of alcohol on mouth cancer ONLY in non-smokers) –Matching Ensures that the distribution of the exposure is the same for all levels of confounder

11/ /7/ Confounding (18) Randomization –Exposure treatment –Subjects randomly assigned to each treatment without regard to other factors. –On average, distribution of other factors will be the same in each treatment group Implies no confounder/exposure correlation  no confounding. –Issues Small sample sizes Chance imbalances Infeasible in many situations Stratified allocation

11/ /7/ Confounding (19) Restriction –Limit the study to people who have the same level of a potential confounder. Study alcohol and mouth cancer only in non- smokers. –Lack of variability in confounder means it can not ‘confound’ There is only one 2X2 table in the stratified analysis –Relatively cheap

11/ /7/ Confounding (20) Restriction (cont) –ISSUES Limits generalizibility Cannot study effect of confounder on risk Limited value with multiple potential confounders Continuous variables? Can only study risk in one level of confounder –exposure X confounder interactions can’t be studied Impact on sample size and feasibility –Alternative: do a regular study with stratified analysis Report separate analyses in each stratum

11/ /7/ Confounding (21) Matching –The process of making a study group and a comparison group comparable with respect to some extraneous factor. Breaks the confounder/exposure link –Most often used in case-control studies. –Usually can’t match on more than 3-4 factors in one study Minimum # of matching groups: 2x2x2x2 = 16 –We’ll talk more about matching on Nov. 30 –KEY POINT: in a case control study, matching does not ‘fix’ confounding – you still have to use stratified analyses.

11/ Matching (1) Example study (case-control) –Identify 200 cases of mouth cancer from a local hospital. –As each new case is found, do a preliminary interview to determine their smoking status. –Identify a non-case who has the same smoking status as the case If there are 150 cases who smoke, there will also be 150 controls who smoke.

11/ Matching (1a) OR = Implies no smoking/outcome link and no confounding Case Control +ve ve Outcome status Smoking

11/ Matching (2) Two main types of matching –Individual (pair) Matches subjects as individuals Twins Right/left eye –Frequency Ensures that the distribution of the matching variable in cases and controls is similar but does not match individual people.

11/ Matching (3) Matching by itself does not fully eliminate confounding in a case-control study! –You must use analytic methods as well Matched OR Stratified analyses Logistic regression models In a cohort study, you don’t have to use these methods although they can help. –But, matching in cohort studies is uncommon

11/ Matching (4) Advantages –Strengthens statistical analysis, especially when the number of cases is small. –Increases study credibility for ‘naive’ readers. –Useful when confounder is a complex, nominal variable (e.g. occupation). Standard statistical methods can be problematic, especially if many levels have very few subjects.

11/ Matching (5) Disadvantages –You can not study the relationship of matched variable to outcome. –Can be costly and time consuming to find matches, especially if you have many matching factors. –Often, some important predictors can not be matched since you have no information on their level in potential controls before doing interview/lab tests Genotype Depression/stress –If matching factor is not a confounder, can reduce precision and power.

11/ Confounding (22) Analysis options –Stratified analysis Divide study into strata based on levels of potential confounding variable(s). Do analysis within each strata to give strata- specific OR or RR. If the strata-specific values are ‘close’, produce an adjusted estimate as some type of average of the strata-specific values. Many methods of adjustment of available. Mantel- Haenzel is most commonly used.

11/ Confounding (23) Stratified analysis (cont) –Strata specific OR’s are: 2.3, 2.6, 3.4 –A ‘credible’ adjusted estimate should be between 2.3 and 3.4. Simple average is: 2.8 –Ignores the number of subjects in the strata. If one group has very few subjects, its OR should contribute less information Weight by # of subjects in each group, e.g.: Mantel-Haenzel does the same thing with different weights

11/ Confounding (24) Stratified analysis (cont) –This approach limits the number of variables which can be controlled or adjusted. –Also hard to apply it to continuous confounders –But, gives information about strata-specific effects and can help identify effect modification. –Used to be very common. Now, no longer widely used in research with case-control studies. –Stratified analysis methods can be applied to cohort studies with person-time.

11/ Confounding (25) Analysis options –Regression modeling The most common approach to confounding Can control multiple factors (often or more) Can control for continuous variables Logistic regression is most popular method for case-control studies –Discussed in last class Cox models (proportional hazard models) are often used in cohort studies.

11/ Summary: Confounding Confounding occurs when a third factor explains away an apparent association This is a major problem with epidemiological research –If you measure a confounder, you can adjust for it in the analysis –Many potential confounders are not measured in study and so can not be controlled [Unmeasured confounders]